World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
80
Citations
32733
World Ranking
984
National Ranking
74

Xin Lu publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Xin Lu sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 182 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Xin Lu D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Xin Lu sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 80 D-Index — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Xin Lu is affiliated with the University of Oxford in the United Kingdom. Their research spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in subfields such as Molecular Biology, Oncology, Surgery, Cell Biology, and Cancer Research.

The scientist has published extensively on a range of topics. Their main research areas include:

  • Cancer Immunotherapy and Biomarkers
  • Esophageal Cancer Research and Treatment
  • Cancer-related Molecular Pathways
  • RNA Modifications and Cancer
  • Cellular Mechanics and Interactions
  • Epigenetics and DNA Methylation
  • Cancer Cells and Metastasis

Xin Lu has contributed to a number of recent publications. Notable papers include:

  • "Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site", 2020, published in Cancer Cell
  • "A deep learning framework for quality assessment and restoration in video endoscopy", 2020, published in Medical Image Analysis
  • "Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer", 2021, published in Theranostics
  • "Human ZBP1 induces cell death-independent inflammatory signaling via RIPK3 and RIPK1", 2022, published in EMBO Reports
  • "Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution", 2020, published in Molecular Cell

The scientist frequently publishes in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Cell Death and Disease
  • SSRN Electronic Journal
  • Cancer Cell

Xin Lu collaborates regularly with several co-authors, including:

  • Richard Owen
  • Mark R. Middleton
  • Felix Zhou
  • Thomas Carroll
  • Benjamin Schuster-Böckler

Best Publications

  • Live or let die: the cell's response to p53

    Karen H. Vousden;Xin Lu

  • Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

    Galluzzi L;Vitale I;Vitale I;Vitale I;Abrams Jm;Alnemri Es

  • Comprehensive genomic profiles of small cell lung cancer

    Julie George;Jing Shan Lim;Se Jin Jang;Yupeng Cun

  • Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    Martin Peifer;Lynnette Fernández-Cuesta;Martin L. Sos;Julie George

  • Differential induction of transcriptionally active p53 following UV or ionizing radiation : defects in chromosome instability syndromes ?

    Xin Lu;David P. Lane

  • X chromosomal abnormalities in basal-like human breast cancer

    Andrea L. Richardson;Zhigang C. Wang;Arcangela De Nicolo;Arcangela De Nicolo;Xin Lu

  • ASPP proteins specifically stimulate the apoptotic function of p53.

    Yardena Samuels-Lev;Daniel J. O'Connor;Daniele Bergamaschi;Giuseppe Trigiante

  • A genomics-based classification of human lung tumors

    Danila Seidel;Thomas Zander;Lukas C. Heukamp;Martin Peifer

  • p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.

    Daniele Bergamaschi;Milena Gasco;Louise Hiller;Alexandra Sullivan

  • A complex barcode underlies the heterogeneous response of p53 to stress

    Fiona Murray-Zmijewski;Elizabeth A. Slee;Xin Lu

  • High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.

    Steffen Fredersdorf;Jorges Burns;Alistair M. Milne;Graham Packham

  • iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human

    Daniele Bergamaschi;Yardena Samuels;Nigel J. O'Neil;Giuseppe Trigiante

  • E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.

    J K Hsieh;S Fredersdorf;T Kouzarides;K Martin

  • Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.

    S Rowan;R L Ludwig;Y Haupt;S Bates

  • To die or not to die: how does p53 decide?

    Elizabeth A Slee;Daniel J O'Connor;Xin Lu

  • Functional regulation of p73 and p63: development and cancer

    Gerry Melino;Xin Lu;Milena Gasco;Tim Crook

  • Residual Embryonic Cells as Precursors of a Barrett's-like Metaplasia

    Xia Wang;Hong Ouyang;Yusuke Yamamoto;Pooja Ashok Kumar

  • RB Regulates the Stability and the Apoptotic Function of p53 via MDM2

    Jung-Kuang Hsieh;Florence S.G Chan;Daniel J O’Connor;Sibylle Mittnacht

  • Epithelial cell polarity: a major gatekeeper against cancer?

    C Royer;X Lu

  • Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo.

    Alexandra Sullivan;Nelofer Syed;Milena Gasco;Daniele Bergamaschi

Frequent Co-Authors

Robert D. Goldin
Robert D. Goldin Imperial College London
Jens Rittscher
Jens Rittscher University of Oxford
Gerry Melino
Gerry Melino University of Rome Tor Vergata
David P. Lane
David P. Lane Karolinska Institute
Yardena Samuels
Yardena Samuels Weizmann Institute of Science
Christopher J. Schofield
Christopher J. Schofield University of Oxford
Hextan Y.S. Ngan
Hextan Y.S. Ngan University of Hong Kong
Karen H. Vousden
Karen H. Vousden The Francis Crick Institute
Ingo Helbig
Ingo Helbig Children's Hospital of Philadelphia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring molecular biology opens the door to a range of rewarding careers in healthcare and research. Many students find that combining a molecular biology background with nursing or healthcare degrees enhances their job prospects and scope of practice.

For those interested in advancing their nursing careers, online bridge programs offer fast-track opportunities. If you’re looking for the 6 month rn to bsn program or want information on streamlined progression with asn to fnp programs, you’ll find solutions that work with your schedule. These programs can lead to specialized roles, including nurse practitioner positions.

Interested in mental health? Becoming a psychiatric nurse practitioner may be a strong career option. The pmhnp salary and job outlook are both attractive. If you’re wondering how long to become nurse practitioner, there are pathways that offer accelerated routes without sacrificing educational quality.

Whether you pursue molecules in the lab or transition to patient care, online degrees and bridge programs provide flexible and accessible career pathways for students of molecular biology.

Best Scientists Citing Xin Lu

Trending Scientists

Recently Published Articles